共 50 条
- [44] Exposure-Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis-Associated Pain CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (11): : 639 - 648
- [48] Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix JOURNAL OF SEXUAL MEDICINE, 2020, 17 (12) : 2427 - 2433